Dr. Justin Levisay, MD
Claim this profileEvanston Hospital
Affiliated Hospitals
Evanston Hospital
Northshore University HealthSystem
Clinical Trials Justin Levisay, MD is currently running
Transseptal ViMAC
for Mitral Valve Disease
A prospective multicenter study enrolling high surgical risk patients with severe mitral annular calcification (MAC) and symptomatic mitral valve dysfunction (severe stenosis, ≥ moderate to severe regurgitation, or mixed ≥ moderate stenosis and ≥ regurgitation). There are 2 Arms in this study: 1) "Transseptal (TS) Valve-in-MAC" (ViMAC) Arm, and 2) Natural History of Disease Registry (NHDR) for patients treated with medical treatment only (which includes patients who meet inclusion criteria but can't be treated with transeptal ViMAC due to the presence of anatomical exclusion criteria or other exclusion criteria) and have not had other procedures that may impact outcomes (i.e., alcohol septal ablation or radiofrequency ablation). The study also includes a Registry of Permanently Unassigned" for subjects who undergo preemptive septal ablation procedures (alcohol or radiofrequency) in anticipation of continuing onto ViMAC arm, but are not accepted in the ViMAC Study arm or the patient chooses not to undergo ViMAC procedure.
Recruiting
1 award
N/A
2 criteria
Carillon Device
for Heart Failure with Mitral Regurgitation
This trial is testing a device called the Carillon Mitral Contour System, which helps the mitral valve in the heart work better. It targets patients with heart failure and a specific valve problem. The device reshapes the valve to improve its function and reduce symptoms.
Recruiting
1 award
N/A
2 criteria
More about Justin Levisay, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Justin Levisay, MD has experience with
- AGENT DCB
- PTCA Balloon Catheter
- Agent Paclitaxel Coated PTCA Balloon Catheter
- ACURATE Neo2™ Transfemoral TAVR System
- Medtronic CoreValve TAVR System
- Edwards SAPIEN 3 TAVR System
Breakdown of trials Justin Levisay, MD has run
Stent Restenosis
Myocardial Infarction
Mitral Regurgitation
Mitral Valve Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Justin Levisay, MD specialize in?
Justin Levisay, MD focuses on Stent Restenosis and Myocardial Infarction. In particular, much of their work with Stent Restenosis has involved treating patients, or patients who are undergoing treatment.
Is Justin Levisay, MD currently recruiting for clinical trials?
Yes, Justin Levisay, MD is currently recruiting for 2 clinical trials in Evanston Illinois. If you're interested in participating, you should apply.
Are there any treatments that Justin Levisay, MD has studied deeply?
Yes, Justin Levisay, MD has studied treatments such as AGENT DCB, PTCA balloon catheter, Agent Paclitaxel Coated PTCA Balloon Catheter.
What is the best way to schedule an appointment with Justin Levisay, MD?
Apply for one of the trials that Justin Levisay, MD is conducting.
What is the office address of Justin Levisay, MD?
The office of Justin Levisay, MD is located at: Evanston Hospital, Evanston, Illinois 60201 United States. This is the address for their practice at the Evanston Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.